Work

Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines

Year: 2014

Type: article

Source: Gene Therapy

DOI: 10.1038/gt.2014.72

Authors: J D Jackson, A M McMorris, J C Roth, J M Coleman, R J Whitley, G Y Gillespie, S L Carroll, J M Markert, K A Cassady

Institutions: University of Alabama at Birmingham, UAB Medicine, Medical University of South Carolina

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, National Cancer Institute

Awards: Engineered HSV For Treatment of Malignant Glioma, G1823729876, CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS, Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors, G5503005519, Molecular Therapeutics for Anaplastic Gliomas

OpenAlex ID: W2083768793

FWCI: 1.965

Cites: 37

Cited by: 21

Related to: 10